Moslemi A R, Tulinius M, Holme E, Oldfors A
Department of Pathology, Sahlgrenska University Hospital, Göteborg, Sweden.
Neuromuscul Disord. 1998 Jun;8(5):345-9. doi: 10.1016/s0960-8966(98)00029-7.
We investigated the distribution in skeletal muscle of mitochondrial DNA (mtDNA) with the tRNA(Lys) A8344G mutation, which is associated with myoclonus epilepsy and ragged red fibres (MERRF) syndrome. Isolated muscle fibre segments (n = 144) from six individuals of two different families carrying the mutation were studied. Two of these individuals were affected by MERRF while four had no or minor clinical symptoms. In one individual with a low overall level of mutated mtDNA (mean 18%) the variation in the proportion of mutated mtDNA between individual muscle fibres ranged from 0 to 80%. This result demonstrates that segregation of the tRNA(Lys) A8344G mutation within a tissue may lead to very marked variation of the level of mutated mtDNA between individual cells. There was a very high apparent threshold level of mutated mtDNA (95.3-97.7%) for expression of histochemical cytochrome c oxidase (COX) deficiency in individual muscle fibres. The results indicated that this apparent threshold level varied slightly between patients. Ultrastructural examination revealed that an appreciable proportion of the mitochondria in COX-positive muscle fibres lacked COX activity. Variation in intercellular and interorganellar distribution of mutated mtDNA in addition to the absolute mtDNA copy number may explain differences in clinical phenotypes in patients with high levels of the tRNA(Lys) A8344G mutation.
我们研究了携带与肌阵挛性癫痫伴蓬毛红纤维(MERRF)综合征相关的tRNA(Lys)A8344G突变的线粒体DNA(mtDNA)在骨骼肌中的分布情况。对来自两个不同家族的6名携带该突变个体的分离肌纤维段(n = 144)进行了研究。其中两名个体患有MERRF,而另外四名个体没有或仅有轻微临床症状。在一名总体突变mtDNA水平较低(平均18%)的个体中,单个肌纤维之间突变mtDNA比例的变化范围为0至80%。这一结果表明,组织内tRNA(Lys)A8344G突变的分离可能导致单个细胞之间突变mtDNA水平出现非常明显的差异。单个肌纤维中组织化学细胞色素c氧化酶(COX)缺乏表达的突变mtDNA表观阈值水平非常高(95.3 - 97.7%)。结果表明,该表观阈值水平在患者之间略有差异。超微结构检查显示,COX阳性肌纤维中有相当比例的线粒体缺乏COX活性。除了绝对mtDNA拷贝数外,突变mtDNA在细胞间和细胞器间分布的差异可能解释了tRNA(Lys)A8344G突变水平较高患者临床表型的差异。